Agilent Technologies, Inc. (NYSE:A) Stock Holdings Increased by Summitry LLC

Summitry LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 3.2% in the 4th quarter, HoldingsChannel reports. The firm owned 478,023 shares of the medical research company’s stock after purchasing an additional 14,854 shares during the quarter. Agilent Technologies makes up 3.1% of Summitry LLC’s portfolio, making the stock its 12th largest holding. Summitry LLC’s holdings in Agilent Technologies were worth $64,218,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the business. CKW Financial Group raised its holdings in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. raised its stake in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after buying an additional 116 shares in the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at $29,000. RPg Family Wealth Advisory LLC bought a new position in Agilent Technologies during the third quarter valued at about $38,000. Finally, Hanson & Doremus Investment Management grew its holdings in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the period.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the firm’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,911 shares of the company’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Stock Down 1.3 %

A stock opened at $120.35 on Wednesday. The company has a 50 day moving average of $135.88 and a two-hundred day moving average of $137.05. The company has a market cap of $34.31 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 3.42 and a beta of 1.11. Agilent Technologies, Inc. has a 12-month low of $117.17 and a 12-month high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.82%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is presently 22.76%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their price target for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Robert W. Baird decreased their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday, February 27th. Finally, Bank of America reduced their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a report on Friday, December 13th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $146.15.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.